This article has been corrected from a previous version, in which Applied Biosystems' president Michael Hunkapiller was referred to as the CEO, and in which a comment by Dr. Hunkapiller regarding sales of 3000 vs. 4000 series mass spectrometers was incorrectly reported as referring to DNA Sequencers. GenomeWeb regrets this inaccuracy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.